BMPR2 and chronic thromboembolic pulmonary hypertension: Mutations in BMPR2 disturb TGF-β signaling and induce pulmonary arterial smooth muscle cell (PASMC) proliferation, suggesting a pivotal role in vascular remodeling, a hallmark of CTEPH (61, 62).